Kifunensine Attenuates Transforming Growth Factor-Beta 1 Induced Cardiac Fibrosis by Inhibiting Transforming Growth Factor-Beta Receptor Complex Formation
inhibitor, shows promise as a potential therapeutic agent for modulating the hyperactivation of transforming growth factor-beta 1 signalling pathways in fibrotic diseases. This study explored kifunensine's effects…

